<DOC>
	<DOCNO>NCT01941953</DOCNO>
	<brief_summary>This phase II trial evaluate efficacy safety Metformin Fluorouracil patient metastatic colorectal cancer ( CRC ) progress Oxaliplatin Irinotecan base chemotherapy .</brief_summary>
	<brief_title>Metformin 5-fluorouracil Refractory Colorectal Cancer .</brief_title>
	<detailed_description>Primary Outcomes Measures : - Disease control Rate 8 week accord RECIST 1.1 ( Tumor response define percentage patient complete response , partial response stable disease best overall response ) . Secondary Outcome Measures : - Progression-free Survival - Overall Survival - Adverse Events ( assess accord Common Toxicity Criteria Adverse Events ( CTCAE ) version 4.0 )</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Inclusion Criteria Histological diagnosis metastatic colorectal adenocarcioma previously treat least two line chemotherapy ( oxaliplatin irinotecan regimen ) mutate KRAS treat least 3 line chemotherapy ( oxaliplatin , irinotecan cetuximab ) KRAS wild type . Disease progression accord radiological clinical assessment . Measurable disease . ECOG Performance 01 . Age 16 year . Normal organic function define follow criterion : Aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) ≤ 2.5 time upper normal limit local laboratory ( LSNLL ) ; Total serum bilirubin ≤ 2.0 x ULNLL ; Absolute neutrophil count ≥ 1,500 / mm3 ; Platelet count ≥ 100,000 / mm3 ; Hemoglobin ≥ 8.0 g / dl ; Serum creatinine ≤ 1.5 x ULNLL Written inform consent enrollment Exclusion Criteria Diabetic patient take metformin . Patients already treat mTOR inhibitor . Hypersensitivity metformin , renal hepatic impairment condition predispose lactic acidosis . History acute myocardial infarction last 6 month Serious illness psychiatric condition . Current participation protocol experimental drug . Suspicion dihidropirimida dehydrogenase ( DPD ) deficiency . Presence active infection . No ability ingest food orally . Patients metastatic disease CNS . Patients underwent major surgery last 4 week . Patients receive chemotherapy last three week . Patients underwent radiotherapy last 2 week receive radiotherapy target lesion , target lesion . Patients use oral anticoagulation ( warfarin ) . Pregnant lactating patient</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Metastatic Colorectal Cancer</keyword>
	<keyword>Fluorouracil</keyword>
</DOC>